Erythropoietin and its carbamylated derivative prevent the development of experimental diabetic autonomic neuropathy in STZ-induced diabetic NOD-SCID mice
Robert E. Schmidt(Washington University in St. Louis), Michael Brines(Northwell Health), Curtis A. Parvin(Washington University in St. Louis), Karen G. Green(Washington University in St. Louis), Denise Dorsey(Washington University in St. Louis), Qinlgi Xiao(Washington University in St. Louis), Dongyan Feng(Washington University in St. Louis), Jin‐Moo Lee(Washington University in St. Louis)
Cited by 37
Related Papers
An Updated Definition of Stroke for the 21st Century
|Stroke|2013|3.5k
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k